Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > FDA

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Oct 25, 2023 1:10pm

113 Views

Post# 35700435

RE:FDA

Because even with an inadequate dose the results were better than all competing treatments.

Dumbeldorfwhite wrote: Why would the FDA grant breakthrough for 25 patients, of which, didn't even get the right dose? My guess is that is the hold up

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project